Marker Therapeutics Inc (MRKR)

[Marv79]

FiercePharma article stated interim results/update in first half of 2018. Earlier this year the deadline for this milestone was Q3/Q4 2017. The delay in producing real scientific data and information continues as it has for years. So we went from 2nd half 2017 to first half 2018. TPIV management has never met a real science/technology deadline in several years, TPIV just pushes forward the deadline, reset expectations and hope they can reset and attract another group of uninformed investors. There are miliions of warrants at slightly less than $3.00/share that couldl be sold from investors who participated in last round of financing so who knows, best to wait for real news, real data, real information on next round of financing versus "BS" presentations and news releases, if not you are just gambling! These guys need to deliver and never had, also, potential for lega actionl and SEC complaints!